About the VHIR
Here at the Vall d'Hebron Research Institute (VHIR) we promote biomedical research, innovation and teaching. Over 1,800 people are seeking to understand diseases today so the treatment can be improved tomorrow.
Research
We are working to understand diseases, to find out how they operate and to create better treatments for patients. Get to know about our groups and their lines of research.
People
People are the centre of the Vall d'Hebron Research Institute (VHIR). This is why we are bound by the principles of freedom of research, gender equality and professional attitudes that HRS4R promotes.
Clinical trials
Our work is not just basic or translational; we are leaders in clinical research. Enter and find about the clinical trials we are conducting and why we are a world reference in this field.
Progress
Our aim is to make the research carried out at the Vall d’Hebron Research Institute (VHIR) a driving force for transformation. How? By identifying new channels and solutions for the promotion of people's health and well-being.
Core facilities
We offer specialist support for researchers, internal and external alike, ranging from specific services to preparing complete projects. All this, from a perspective of quality and speed of response.
News
We offer you a gateway for staying up to date on everything going on at the Vall d’Hebron Research Institute (VHIR), from the latest news to future solidarity activities and initiatives that we are organising.
Speaker: Dr. Zsuzanna McMahan, Rheumatologist, associate professor at the University of Texas Health Science Center at Houston (UTHealth Houston)
Dr. Zsuzsanna McMahan is a rheumatologist specializing in systemic sclerosis, with a focus on gastrointestinal complications. She trained at UTHealth Houston and Johns Hopkins, where she also earned a Master in Health Sciences and spent 11 years on faculty. In 2023, she joined UTHealth Houston as Co-Director of the Scleroderma Program. Her NIH-funded research includes clinical and translational studies and treatment trials in scleroderma. She has authored over 60 publications and book chapters. Dr. McMahan co-leads the Gastrointestinal Working Group for the Scleroderma Clinical Trials Consortium and the GI ad hoc committee of the World Scleroderma Foundation. She is actively involved in the American College of Rheumatology (ACR).
Host: Dr. Alfredo Guillén Del Castillo, Internal Medicine Service and associate professor at the Autonomous University of Barcelona.